Exploring the Role of Etanercept in Managing Juvenile Idiopathic Arthritis

Speciality: Rheumatology

Description:

A warm welcome to all the medical professionals in this interesting session on an overview of juvenile idiopathic arthritis and the role of etanercept in juvenile idiopathic arthritis. 

Rheumatoid arthritis is an autoimmune disease that usually affects a majority of the adult population, however, if it occurs in children under 16 is called juvenile idiopathic arthritis (JIA). It can cause severe pain due to the stiffness of the joints and affect the mobility of the joints.

A detailed discussion is provided on the occurrence and management of juvenile idiopathic arthritis in children. JIA can cause serious complications, like growth problems, joint damage, and eye inflammation. 

TNF alpha inhibitors and JAK inhibitors play a key role in altering immune responses in such cases. Etanercept, a TNF-inhibiting drug, can be an advanced treatment option in managing juvenile idiopathic arthritis. These are mostly used for people with different types of rheumatic diseases. 

Thus, listen to the webinar, grab the knowledge that is shared, and follow HiDoc for more such exciting webinar sessions.
 

See More Webinars @ Hidoc Webinars